Glasgow is hosting the world leading EMBC as a result of the long efforts of HCi Viocare’s Diabetes Technology Research Director, Professor Bill Sandham

Glasgow is hosting the 44th EMBC, the world’s largest International Conference for biomedical engineering, in 2022 at the SECC. This significant development, which constitutes a deep recognition and high acceptance of the British-Scottish scientific community, has been secured by Professor Bill Sandham, HCi Viocare’s Director, Diabetes Technology Research and member of the company’s Scientific Advisory Board, together with Professor Christopher James, Warwick University

This annual conference is held under the auspices of the IEEE (Institute of Electrical and Electronics Engineers), which is the world's largest technical professional organization “dedicated to advancing technology for the benefit of humanity”. IEEE is the trusted “voice” for engineering, computing and technology information around the globe, and there are more than 430,000 IEEE members in more than 160 countries.

The UK has deep roots in biomedical engineering, having recorded many major innovations that have been globally implemented over the years, and also having extensive academic presence and top-rated industry support. It is therefore particularly relevant, and indeed surprising, that EMBC-2022 represents the first EMBC conference in the UK.

Professor Sandham is a Senior Member of the IEEE. With a 42 year professional career in electronic and electrical engineering, he is an expert in diabetes technology and has a vital role in HCi Viocare’s R&D achievements.  He has devoted a large part of his career to instill the conditions to ensure this important conference will be hosted in his home city of Glasgow.

He comments: ‘Securing the EMBC conference in Glasgow, not only was a great breakthrough, but also proves that HCi Viocare’s technology and scientists play a major part in the global biomedical engineering sector, and have a high professional standing. It is excellent that HCi Viocare will be the closest biomedical engineering company to the SECC conference venue”.  And he adds, “There’s a lot of hard work in front of us, but EMBC-2022 offers tremendous opportunities for the City of Glasgow and for the many biomedical engineering companies and academic institutions within the UK”.

Dr Christos Kapatos, HCi Viocare’s co-founder and CTO  stated: “The HCi Viocare team welcome this significant development with a sense of pride and gratitude. We wish Professor Sandham every success and we look forward to our engagement”. 

See more information of this year’s EMBC: http://embc.embs.org/2016/